DMG-PEG2000-NH2: A Benchmark NH2-PEG Linker for Liposomal and LNP Drug Delivery

Executive Summary: DMG-PEG2000-NH2 is an amine-functionalized polyethylene glycol (PEG) linker with a molecular weight of 2528, designed for efficient amide bond formation with carboxyl groups in biomolecules (APExBIO). It enables the construction of lipid nanoparticle (LNP) and liposomal drug carriers by enhancing solubility, stability, and biocompatibility of the cargo (see comparative analysis). The product exhibits high solubility in DMSO (≥51.6 mg/mL), ethanol (≥52 mg/mL), and water (≥25.3 mg/mL), with recommended storage at -20°C. Its validated purity (>90%), and availability of COA/MSDS, support reproducible results in drug delivery and bioconjugation workflows (Chen et al., 2021). APExBIO provides this reagent as SKU M2006 to the global research community.

Biological Rationale

Advances in therapeutic delivery demand linkers that improve biomolecule solubility and compatibility in physiological environments (Chen et al., 2021). Polyethylene glycol (PEG) derivatives, such as DMG-PEG2000-NH2, are widely used to shield drugs and carriers from immune recognition, prolonging circulation time and reducing immunogenicity. The primary amine group on DMG-PEG2000-NH2 enables covalent attachment via amide bond formation to carboxyl-containing biomolecules including proteins, peptides, and oligonucleotides. This facilitates the assembly of stable, biocompatible liposomes and lipid nanoparticles (LNPs). These systems are central to modern drug delivery—especially for nucleic acids like siRNA, which require encapsulation for in vivo stability and targeted delivery. By increasing hydrophilicity and minimizing aggregation, NH2-PEG derivatives support highly reproducible bioconjugation and formulation outcomes (compare mechanistic insights).

Mechanism of Action of DMG-PEG2000-NH2

DMG-PEG2000-NH2 is a bifunctional molecule: it possesses a dimyristoyl glycerol lipid anchor and a PEG2000 chain terminated with a primary amine (-NH2). The lipid anchor embeds in lipid bilayers, while the PEG and amine extend outward. The -NH2 group reacts with carboxyl groups on biomolecules or activated surfaces, forming a stable amide bond (Chen et al., 2021). This reaction is typically performed in aqueous buffer (pH 7–8) using carbodiimide-mediated coupling (e.g., EDC/NHS chemistry). The PEG chain provides steric stabilization, enhances solubility, and reduces protein adsorption, thus improving colloidal stability and biocompatibility of the resulting conjugates. In liposomal and LNP applications, the DMG anchor integrates into the membrane, while the PEG-NH2 moiety remains available for further conjugation or surface modification. This modularity underpins DMG-PEG2000-NH2's utility in creating multifunctional drug carriers.

Evidence & Benchmarks

• PEGylation of lipid nanoparticles with DMG-PEG2000-NH2 improves particle stability and prolongs in vivo circulation time (see Chen et al., 2021).
• Primary amine-terminated PEGs enable efficient, site-specific amide bond formation with carboxyl-functionalized biomolecules under mild conditions (reaction conditions, Table 1).
• APExBIO's DMG-PEG2000-NH2 (SKU M2006) achieves ≥90% purity and is supplied with validated COA/MSDS for reproducible research (APExBIO product page).
• Solubility benchmarks: ≥51.6 mg/mL in DMSO, ≥52 mg/mL in ethanol, and ≥25.3 mg/mL in water, facilitating flexible formulation workflows (APExBIO documentation).
• NH2-PEG derivatives are proven to reduce aggregation and enhance drug loading efficiency in liposomal siRNA encapsulation (mechanistic protocol comparison).

Applications, Limits & Misconceptions

DMG-PEG2000-NH2 is engineered for:

• Lipid nanoparticle (LNP) and liposome surface PEGylation to improve circulation and reduce immunogenicity.
• Site-specific bioconjugation with proteins, peptides, oligonucleotides, or small molecules via amide bond formation.
• Encapsulation and delivery of siRNA, mRNA, or small molecule drugs in pharmaceutical research.
• Stabilization of colloidal suspensions by preventing aggregation and opsonization.

For a scenario-driven exploration of applications and troubleshooting, see this in-depth guide, which expands on practical laboratory workflows. This article updates previous reviews by providing quantitative solubility and purity benchmarks as well as recent synthetic and mechanistic data.

Common Pitfalls or Misconceptions

• Not all carboxylated targets are accessible: Sterically hindered or buried carboxyl groups may not react efficiently with PEG-NH2.
• PEGylation is not universally beneficial: Excessive PEGylation can reduce cell uptake or activity of conjugated biomolecules.
• Storage stability: Long-term storage of DMG-PEG2000-NH2 solutions, especially at room temperature, can result in hydrolysis or loss of reactivity. Solid form should be stored at -20°C.
• Batch variability: Purity and MW distribution can impact conjugation efficiency; always verify with supplied COA/MSDS.
• Not suitable for non-lipid systems: The DMG anchor is optimized for lipid membranes and may not integrate into other polymeric systems.

Workflow Integration & Parameters

DMG-PEG2000-NH2 is typically dissolved in DMSO, ethanol, or water for use. For amide coupling, solutions are prepared in buffer (e.g., MES, pH 6.0) with EDC and NHS as activating agents. Reaction is conducted at room temperature for 1–2 hours. For LNP/liposome PEGylation, the product is co-dissolved with lipid components and hydrated under sterile conditions. Recommended concentrations are 0.5–5 mol% relative to total lipid for optimal surface modification (protocol details). Post-conjugation, the product should be purified to remove unreacted linker. APExBIO supplies DMG-PEG2000-NH2 with full quality control, enabling reproducible integration into diverse workflows. For detailed troubleshooting and strategy, see this mechanistic analysis, which contrasts with this article by focusing on translational and regulatory considerations.

Conclusion & Outlook

DMG-PEG2000-NH2 is a validated, high-purity NH2-PEG derivative with robust performance in lipid nanoparticle and liposomal drug delivery workflows. Its primary amine enables efficient, site-specific conjugation, while the PEG and DMG moieties assure solubility and membrane integration. APExBIO's commitment to quality and documentation positions this product as a reference standard for pharmaceutical and biochemical research. Ongoing innovation in PEGylation chemistry and LNP engineering will further expand the utility of DMG-PEG2000-NH2 in emerging therapeutic modalities. For order details or technical support, refer to the official product page.